This work is licensed under a Creative Commons Attribution 4.0 International License.
General Information
DRACP ID DRACP04035
Peptide Name
Sequence VCRKPVVCRKPVVCRKPVVCRKPVVCRKPV
Sequence Length 30
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C150H272N50O31S5
Absent amino acids ADEFGHILMNQSTWY
Common amino acids V
Mass 394986
Pl 11.27
Basic residues 10
Acidic residues 0
Hydrophobic residues 10
Net charge 10
Boman Index -5555
Hydrophobicity 15
Aliphatic Index 96.67
Half Life
Mammalian: 100 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 250
Absorbance 280nm 8.62
Polar residues 5
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 32706256
Title Rational Avoidance of Protease Cleavage Sites and Symmetrical End-Tagging Significantly Enhances the Stability and Therapeutic Potential of Antimicrobial Peptides
Doi Not available
Year 2020
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 16415
This work is licensed under a Creative Commons Attribution 4.0 International License.